CAS: 946415-13-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Pamrevlumab REF: TM-T76804CAS: 946415-13-0 | 95% | 134.00 €~1,267.00 € | Wed 08 Jan 25 |
 | Pamrevlumab REF: 3D-CLA1394CAS: 946415-13-0 | - - - | To inquire | Tue 21 Jan 25 |
Pamrevlumab
CAS:946415-13-0
FG-3019 (Pamrevlumab), a human antibody, targets CTGF, potentially treating idiopathic pulmonary fibrosis.
Purity:
95%
Color and Shape:
Liquid
Ref: TM-T76804
| 1mg | 134.00 € | ||
| 5mg | 385.00 € | ||
| 10mg | 612.00 € | ||
| 25mg | 913.00 € | ||
| 50mg | 1,267.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Pamrevlumab
CAS:946415-13-0
Anti-CTGF protein humanized monoclonal antibody; idiopathic pulmonary fibrosis and pancreatic cancer treatment
Ref: 3D-CLA1394
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
